Roscovitine-Derived, Dual-Specificity Inhibitors of Cyclin-Dependent Kinases and Casein Kinases 1
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Cyclin-dependent kinases (CDKs) and casein kinases 1 (CK1) are involved in the two key molecular features of Alzheimer's disease, production of amyloid-beta peptides (extracellular plaques) and hyper-phosphorylation of Tau (intracellular neurofibrillary tangles). A series of 2,6,9-trisubstituted purines, structurally related to the CDK inhibitor roscovitine, have been synthesized. They mainly differ by the substituent on the C-6 position. These compounds were screened for kinase inhibitory activities and antiproliferative effects. Several biaryl derivatives displayed potent inhibition of both CDKs and CK1. In particular, derivative 13a was a potent inhibitor of CDK1/cyclin B (IC 50: 220 nM), CDK5/p25 (IC 50: 80 nM), and CK1 (IC 50: 14 nM). Modeling of these molecules into the ATP-binding pocket of CK1delta provided a rationale for the increased selectivity toward this kinase. 13a was able to prevent the CK1-dependent production of amyloid-beta in a cell model. CDK/CK1 dual-specificity inhibitors may have important applications in Alzheimer's disease and cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DRF05322, a CR8-related inhibitor that carries a differently linked phenylpyridine ring system (Fig. 3a, c), induced binding with two-fold lower affinity than CR8 (Extended Data Fig. 8a).”
From The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K (2020) · cites this paper as [22]
Citations
Cites
Boys, S. F., & Bernardi, F. (1970) · Molecular Physics · doi:10.1080/00268977000101561 · Cited by 22,188
Mohamadi, F., Richards, N. G. J., Guida, W. C., Liskamp, R., Lipton, M., Caufield, C., Chang, G., Hendrickson, T., & Still, W. C. (1990) · Journal of Computational Chemistry · doi:10.1002/jcc.540110405 · Cited by 3,757
ESPript: analysis of multiple sequence alignments in PostScript.
Gouet, P., Courcelle, E., Stuart, D. I., & M√©toz, F. (1999) · Bioinformatics · doi:10.1093/bioinformatics/15.4.305 · Cited by 2,951
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
A small molecule–kinase interaction map for clinical kinase inhibitors
Fabian, M. A., Biggs, W. H., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1068 · Cited by 1,892
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Self-citationGSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors
Gray, N. S., Wodicka, L., Thunnissen, A.-M. W. H., Norman, T. C., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., LeClerc, S., Meijer, L., et al. (1998) · Science · doi:10.1126/science.281.5376.533 · Cited by 808
Self-citationLeclerc, S., Garnier, M., Hoessel, R., Marko, D., Bibb, J. A., Snyder, G. L., Greengard, P., Biernat, J., Wu, Y.-Z., Mandelkow, E.-M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m002466200 · Cited by 723
Self-citationThe casein kinase 1 family: participation in multiple cellular processes in eukaryotes
Knippschild, U., Gocht, A., Wolff, S., Huber, N., Löhler, J., & Stöter, M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.12.011 · Cited by 601
Pharmacological inhibitors of glycogen synthase kinase 3
MEIJER, L., FLAJOLET, M., & GREENGARD, P. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.07.006 · Cited by 584
Self-citationKinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration
Wang, J., Grundke‐Iqbal, I., & Iqbal, K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05226.x · Cited by 553
Pharmacological inhibitors of cyclin-dependent kinases
Knockaert, M., Greengard, P., & Meijer, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02071-0 · Cited by 537
Self-citationRossi, A. G., Sawatzky, D. A., Walker, A., Ward, C., Sheldrake, T. A., Riley, N. A., Caldicott, A., Martinez-Losa, M., Walker, T. R., Duffin, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1468 · Cited by 509
Hanger, D. P., Byers, H. L., Wray, S., Leung, K.-Y., Saxton, M. J., Seereeram, A., Reynolds, C. H., Ward, M. A., & Anderton, B. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703269200 · Cited by 455
GSK-3 is essential in the pathogenesis of Alzheimer's disease
Takashima, A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s335 · Cited by 396
Roscovitine and Other Purines as Kinase Inhibitors. From Starfish Oocytes to Clinical Trials
Meijer, L., & Raymond, E. (2003) · ChemInform · doi:10.1002/chin.200336265 · Cited by 362
Self-citationRoscovitine Targets, Protein Kinases and Pyridoxal Kinase
Bach, S., Knockaert, M., Reinhardt, J., Lozach, O., Schmitt, S., Baratte, B., Koken, M., Coburn, S. P., Tang, L., Jiang, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500806200 · Cited by 356
Self-citationThe purines: Potent and versatile small molecule inhibitors and modulators of key biological targets
Legraverend, M., & Grierson, D. S. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.060 · Cited by 330
Rockenstein, E., Torrance, M., Adame, A., Mante, M., Bar-on, P., Rose, J. B., Crews, L., & Masliah, E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4321-06.2007 · Cited by 288
The Chemodiversity of Purine as a Constituent of Natural Products
Rosemeyer, H. (2004) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490033 · Cited by 283
Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine
Bukanov, N. O., Smith, L. A., Klinger, K. W., Ledbetter, S. R., & Ibraghimov-Beskrovnaya, O. (2006) · Nature · doi:10.1038/nature05348 · Cited by 276
Chang, Y.-T., Gray, N. S., Rosania, G. R., Sutherlin, D. P., Kwon, S., Norman, T. C., Sarohia, R., Leost, M., Meijer, L., & Schultz, P. G. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80048-9 · Cited by 268
Self-citationCdk5 deregulation in the pathogenesis of Alzheimer's disease
Cruz, J. C., & Tsai, L.-H. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.001 · Cited by 258
p25/Cyclin-Dependent Kinase 5 Induces Production and Intraneuronal Accumulation of Amyloid β In Vivo
Cruz, J. C., Kim, D., Moy, L. Y., Dobbin, M. M., Sun, X., Bronson, R. T., & Tsai, L.-H. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3133-06.2006 · Cited by 198
Regulation of Alzheimer's disease amyloid-β formation by casein kinase I
Flajolet, M., He, G., Heiman, M., Lin, A., Nairn, A. C., & Greengard, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611236104 · Cited by 174
Self-citationThe Role of Tau Phosphorylation in the Pathogenesis of Alzheimers Disease
Mi, K., & Johnson, G. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025279 · Cited by 167
Casein Kinase 1 Delta Phosphorylates Tau and Disrupts Its Binding to Microtubules
Li, G., Yin, H., & Kuret, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314116200 · Cited by 159
Human members of the eukaryotic protein kinase family
Kostich, M., English, J., Madison, V., Gheyas, F., Wang, L., Qiu, P., Greene, J., & Laz, T. M. (2002) · Genome Biology · doi:10.1186/gb-2002-3-9-research0043 · Cited by 125
The Role of CDK5/P25 Formation/Inhibition in Neurodegeneration
(2006) · Drug News & Perspectives · doi:10.1358/dnp.2006.19.8.1043961 · Cited by 124
Fischer, P. M. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365062 · Cited by 116
NMR Method for the Determination of Solute Hydrogen Bond Acidity
Abraham, M. H., Abraham, R. J., Byrne, J. J., & Griffiths, L. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo052631n · Cited by 97
Phosphorylation of τ Protein by Casein Kinase‐1 Converts It to an Abnormal Alzheimer‐Like State
Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031420.x · Cited by 81
Crystal Structure of Pyridoxal Kinase in Complex with Roscovitine and Derivatives
Tang, L., Li, M.-H., Cao, P., Wang, F., Chang, W.-R., Bach, S., Reinhardt, J., Ferandin, Y., Galons, H., Wan, Y., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500805200 · Cited by 81
Self-citationMultiple Roles for Glycogen Synthase Kinase-3 as a Drug Target in Alzheimers Disease
Huang, H.-C., & Klein, P. (2006) · Current Drug Targets · doi:10.2174/1389450110607011389 · Cited by 76
Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse.
Nutley, B. P., Raynaud, F. I., Wilson, S. C., Fischer, P. M., Hayes, A., Goddard, P. M., McClue, S. J., Jarman, M., Lane, D. P., & Workman, P. (2005) · PubMed · Cited by 71
Purification of CK1 by affinity chromatography on immobilised axin
Reinhardt, J., Ferandin, Y., & Meijer, L. (2007) · Protein Expression and Purification · doi:10.1016/j.pep.2007.02.020 · Cited by 70
Self-citationEditorial: Drug Discovery Process for Kinease Inhibitors
Weinmann, H., & Metternich, R. E. (2005) · ChemBioChem · doi:10.1002/cbic.200500034 · Cited by 65
The Purinome, a Complex Mix of Drug and Toxicity Targets
Haystead, T. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777812059 · Cited by 63
Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat
Vita, M. F., Abdel‐Rehim, M., Olofsson, S., Hassan, Z., Meurling, L., Sidén, Å., Sidén, M., Pettersson, T., & Hassan, M. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.02.001 · Cited by 61
Myrianthopoulos, V., Magiatis, P., Ferandin, Y., Skaltsounis, A., Meijer, L., & Mikros, E. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070077z · Cited by 58
Self-citationInhibitors of Cyclin-dependent Kinases as Anti-tumor Agents
Smith, P. J., & Yue, E. W. (2006) · CRC Press eBooks · doi:10.1201/9781420005400 · Cited by 55
Pei, J.-J., Braak, H., Gong, C., Grundke, I., Iqbal, K., Winblad, B. G., & Cowburn, R. F. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0565-1 · Cited by 51
Resin-Capture and Release Strategy toward Combinatorial Libraries of 2,6,9-Substituted Purines
Ding, S., Gray, N. S., Ding, Q., Wu, X., & Schultz, P. G. (2002) · Journal of Combinatorial Chemistry · doi:10.1021/cc010080i · Cited by 47
Protein kinase resource: An integrated environment for phosphorylation research
Niedner, R. H., Buzko, O. V., Haste, N. M., Taylor, A., Gribskov, M., & Taylor, S. S. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20825 · Cited by 47
A Concise and Traceless Linker Strategy toward Combinatorial Libraries of 2,6,9-Substituted Purines
Ding, S., Gray, N. S., Ding, Q., & Schultz, P. G. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo016010f · Cited by 46
Traceless solid-phase synthesis of 2,6,9-trisubstituted purines from resin bound 6-thiopurines
Brun, V., Legraverend, M., & Grierson, D. S. (2002) · Tetrahedron · doi:10.1016/s0040-4020(02)00905-5 · Cited by 43
Ribas, J., & Boix, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.019 · Cited by 36
Haesslein, J., & Jullian, N. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023393291 · Cited by 31
Cdh1-APC/C, cyclin B-Cdc2, and Alzheimer’s disease pathology
Aulia, S., & Tang, B. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.059 · Cited by 29
Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitorR-roscovitine in the mouse
Nutley, B. P., Raynaud, F. I., Wilson, S. C., Fischer, P. M., Hayes, A., Goddard, P. M., McClue, S. J., Jarman, M., Lane, D. P., & Workman, P. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.125.4.1 · Cited by 28
Genetic Association of CDC2 with Cerebrospinal Fluid Tau in Alzheimer’s Disease
Johansson, A., Zetterberg, H., Hampel, H. J., Büerger, K., Prince, J. A., Minthon, L., Wahlund, L., & Blennow, K. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000088634 · Cited by 16
Research works printed but not linked: 6
- Manning G., 2002, Science, 298, 1933
- Meijer L., 2003, Acc. Chem. Res., 36, 417, 10.1021/ar0201198 · doi:10.1021/ar0201198
- Meijer L., 2006, CDK Inhibitors and their Potential as Antitumor Agents, 2, 187
- Menn B., 2008, Ann. Neurol.
- Rockenstein E., 2007, J. Neurosci., 27, 1981, 10.1523/JNEUROSCI.4321-06.2007 · DOI · Paper page
- Bettayeb K., 2008, Oncogene
Cited by
Tau protein kinases: Involvement in Alzheimer's disease
Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., Yardin, C., & Terro, F. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.003 · Cited by 631
Circadian Timing in Cancer Treatments
Lévi, F., Okyar, A., Dulong, S., Innominato, P. F., & Clairambault, J. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094626 · Cited by 476
León, R., Garcia, A. G., & Marco‐Contelles, J. (2013) · Medicinal Research Reviews · doi:10.1002/med.20248 · Cited by 440
The Role of Tau in Alzheimer's Disease and Related Disorders
Medeiros, R., Baglietto‐Vargas, D., & LaFerla, F. M. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00177.x · Cited by 432
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Słabicki, M., Kozicka, Z., Petzold, G., Li, Y.-D., Manojkumar, M., Bunker, R. D., Donovan, K. A., Sievers, Q. L., Koeppel, J., Suchyta, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2374-x · Cited by 433
Metadata
- Authors
- Oumata, N., Bettayeb, K., Ferandin, Y., Demange, L., Lopez-Giral, A., Goddard, M.-L., Myrianthopoulos, V., Mikros, E., Flajolet, M., Greengard, P., Meijer, L., & Galons, H.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Laboratoire de Chimie Organique 2, INSERM U 648, Université Paris-Descartes, 4 avenue de l’Observatoire, 75270 Paris cedex 06, France, CNRS, Protein Phosphorylation & Human Disease Group, Station Biologique, B.P. 74, 29682 Roscoff cedex, Bretagne, France, Department of Pharmacy, University of Athens, GR-15771 Athens, Greece, Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399
- Corresponding author
- Meijer, Laurent
- Galons, Hervé
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-08-13
- Volume
- 51
- Issue
- 17
- Pages
- 5229-5242
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1989404928
- Semantic Scholar
- 7e66b22e8142658b493b4a260facbc3977df92ba
- Cited by
- 139
- References
- 54
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 8 · 2023: 5 · 2022: 9 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 5 · 2017: 10 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 12 · 2012: 12
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- National Institute on Aging (AG09464, P01AG009464)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- cyclin-dependent kinases, casein kinase 1, Alzheimer's disease, amyloid-beta production, tau hyperphosphorylation, CDK1/cyclin B, CDK5/p25, antiproliferative activity, kinase inhibitors
- MeSH terms
- Roscovitine, Animals, Binding Sites, Cell Line, Humans, Models, Molecular, Purines, Structure-Activity Relationship, Amyloid beta-Peptides, Cyclin-Dependent Kinases, Inhibitory Concentration 50, Casein Kinase I, Protein Kinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.